These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 15567193)

  • 1. Benznidazole, a drug used in Chagas' disease, ameliorates LPS-induced inflammatory response in mice.
    Pascutti MF; Pitashny M; Nocito AL; Guermonprez P; Amigorena S; Wietzerbin J; Serra E; Bottasso O; Revelli S
    Life Sci; 2004 Dec; 76(6):685-97. PubMed ID: 15567193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Benznidazole, a drug employed in the treatment of Chagas' disease, down-regulates the synthesis of nitrite and cytokines by murine stimulated macrophages.
    Revelli S; Le Page C; Piaggio E; Wietzerbin J; Bottasso O
    Clin Exp Immunol; 1999 Nov; 118(2):271-7. PubMed ID: 10540190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beneficial effects of benznidazole during an infectious-based situation of systemic inflammatory response: cecal ligation and puncture.
    Manarin R; Bottasso E; Bottasso O; Serra E; Revelli S
    Am J Trop Med Hyg; 2008 Nov; 79(5):793-6. PubMed ID: 18981524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. iNOS-targeted 10-23 DNAzyme reduces LPS-induced systemic inflammation and mortality in mice.
    Verma N; Tripathi SK; Chaudhury I; Das HR; Das RH
    Shock; 2010 May; 33(5):493-9. PubMed ID: 19823115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroprotective effects of cyclooxygenase-2 inhibitor celecoxib against toxicity of LPS-stimulated macrophages toward motor neurons.
    Huang Y; Liu J; Wang LZ; Zhang WY; Zhu XZ
    Acta Pharmacol Sin; 2005 Aug; 26(8):952-8. PubMed ID: 16038627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathogenic role of interleukin-6 in the development of sepsis. Part II: Significance of anti-interleukin-6 and anti-soluble interleukin-6 receptor-alpha antibodies in a standardized murine contact burn model.
    Pallua N; Low JF; von Heimburg D
    Crit Care Med; 2003 May; 31(5):1495-501. PubMed ID: 12771624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of inducible nitric-oxide synthase expression by (5R)-5-hydroxytriptolide in interferon-gamma- and bacterial lipopolysaccharide-stimulated macrophages.
    Zhou R; Zheng SX; Tang W; He PL; Li XY; Yang YF; Li YC; Geng JG; Zuo JP
    J Pharmacol Exp Ther; 2006 Jan; 316(1):121-8. PubMed ID: 16166270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thymocyte depletion during acute Trypanosoma cruzi infection in C57BL/6 mice is partly reverted by lipopolysaccharide pretreatment.
    Roggero E; Piazzon I; Nepomnaschy I; Perez A; Velikovsky A; Revelli S; Bottasso O
    FEMS Immunol Med Microbiol; 2004 Jun; 41(2):123-31. PubMed ID: 15145456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Control of endotoxin shock by the dried preparation of low virulent Streptococcus pyogenes OK-432.
    Nose M; Uzawa A; Nomura M; Ikarashi Y; Nakata Y; Akashi M; Suzuki G
    Cell Immunol; 1998 Sep; 188(2):97-104. PubMed ID: 9756639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beneficial effects of ApoA-I on LPS-induced acute lung injury and endotoxemia in mice.
    Yan YJ; Li Y; Lou B; Wu MP
    Life Sci; 2006 Jun; 79(2):210-5. PubMed ID: 16574162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Benznidazole treatment attenuates liver NF-κB activity and MAPK in a cecal ligation and puncture model of sepsis.
    Ronco MT; Manarin R; Francés D; Serra E; Revelli S; Carnovale C
    Mol Immunol; 2011 Mar; 48(6-7):867-73. PubMed ID: 21269697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of lipopolysaccharide-inducible nitric oxide synthase and IL-1beta through suppression of NF-kappaB activation by 3-(1'-1'-dimethyl-allyl)-6-hydroxy-7-methoxy-coumarin isolated from Ruta graveolens L.
    Raghav SK; Gupta B; Shrivastava A; Das HR
    Eur J Pharmacol; 2007 Mar; 560(1):69-80. PubMed ID: 17292351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergistic therapeutic potential of dexamethasone and L-arginine in lipopolysaccharide-induced septic shock.
    Chatterjee S; Premachandran S; Shukla J; Poduval TB
    J Surg Res; 2007 Jun; 140(1):99-108. PubMed ID: 17292408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitory effect of naringin on lipopolysaccharide (LPS)-induced endotoxin shock in mice and nitric oxide production in RAW 264.7 macrophages.
    Kanno S; Shouji A; Tomizawa A; Hiura T; Osanai Y; Ujibe M; Obara Y; Nakahata N; Ishikawa M
    Life Sci; 2006 Jan; 78(7):673-81. PubMed ID: 16137700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tetrandrine increased the survival rate of mice with lipopolysaccharide-induced endotoxemia.
    Lin TY; Tseng SH; Li SJ; Chen JC; Shieh JS; Chen Y
    J Trauma; 2009 Feb; 66(2):411-7. PubMed ID: 19204515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tectorigenin inhibits IFN-gamma/LPS-induced inflammatory responses in murine macrophage RAW 264.7 cells.
    Pan CH; Kim ES; Jung SH; Nho CW; Lee JK
    Arch Pharm Res; 2008 Nov; 31(11):1447-56. PubMed ID: 19023541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-inflammatory and antioxidative effects of propofol on lipopolysaccharide-activated macrophages.
    Chen RM; Chen TG; Chen TL; Lin LL; Chang CC; Chang HC; Wu CH
    Ann N Y Acad Sci; 2005 May; 1042():262-71. PubMed ID: 15965071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deficient control of Trypanosoma cruzi infection in C57BL/6 mice is related to a delayed specific IgG response and increased macrophage production of pro-inflammatory cytokines.
    Pérez AR; Tamae-Kakazu M; Pascutti MF; Roggero E; Serra E; Revelli S; Bottasso O
    Life Sci; 2005 Sep; 77(16):1945-59. PubMed ID: 15916779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective effects of interleukin-6 in lipopolysaccharide (LPS)-induced experimental endotoxemia are linked to alteration in hepatic anti-oxidant enzymes and endogenous cytokines.
    Nandi D; Mishra MK; Basu A; Bishayi B
    Immunobiology; 2010 Jun; 215(6):443-51. PubMed ID: 19773091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment with Y-40138, a multiple cytokine production modulator, inhibits lipopolysaccharide- or tumour necrosis factor-alpha-induced production of pro-inflammatory cytokines and augments interleukin-10.
    Fukuda T; Hisadome M; Komatsu H
    J Pharm Pharmacol; 2005 Nov; 57(11):1461-6. PubMed ID: 16259779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.